Altimmune UK Limited
Records under this name other than the patents Altimmune UK Limited holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 7 patents it holds.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 11,382,969 | Vaccines Against Hepatitis B Virus Lapsed on the fee record Ended Jul 12, 2026 · High confidence | Lapsed on the fee record | Ended Jul 12, 2026 | High confidence |
| US 9,962,453 | Immunogenic compound Lapsed on the fee record Ended May 8, 2026 · USPTO record | Lapsed on the fee record | Ended May 8, 2026 | USPTO record |
| US 8,642,531 | Influenza antigen delivery vectors and constructs Lapsed on the fee record Ended Feb 4, 2026 · USPTO record | Lapsed on the fee record | Ended Feb 4, 2026 | USPTO record |
| US 7,687,455 | Antigen delivery vectors and constructs Term ended Term ended Aug 29, 2025 · USPTO record | Term ended | Term ended Aug 29, 2025 | USPTO record |
| US 8,110,540 | Antigen delivery vectors and constructs Term ended Ended no later than Apr 1, 2025 · USPTO record | Term ended | Ended no later than Apr 1, 2025 | USPTO record |
| US 8,110,541 | Antigen delivery vectors and constructs Term ended Ended no later than Apr 1, 2025 · USPTO record | Term ended | Ended no later than Apr 1, 2025 | USPTO record |
| US 8,759,281 | Antigen delivery vectors and constructs Term ended Ended no later than Apr 1, 2025 · USPTO record | Term ended | Ended no later than Apr 1, 2025 | USPTO record |
| US 11,066,353 | Antigen delivery vectors and constructs Term ended Ended no later than Apr 1, 2025 · USPTO record | Term ended | Ended no later than Apr 1, 2025 | USPTO record |
| US 10,849,984 | Immunogenic compound Lapsed on the fee record Ended Dec 1, 2024 · USPTO record | Lapsed on the fee record | Ended Dec 1, 2024 | USPTO record |
| US 9,446,143 | Influenza antigen delivery vectors and constructs Lapsed on the fee record Ended Sep 20, 2024 · USPTO record | Lapsed on the fee record | Ended Sep 20, 2024 | USPTO record |